Yes — routine primary care can lower dementia risk, mainly by controlling the everyday conditions that damage the brain over time. The 2024 Lancet Commission on dementia prevention found that addressing 14 modifiable risk factors — including hypertension, diabetes, obesity, smoking, depression, hearing loss, and high LDL cholesterol — could prevent or delay 45% of dementia cases worldwide, and most of those factors are already managed inside a regular primary care visit, according to the Lancet Commission.
The strongest single piece of evidence is blood pressure control. A large trial run through primary-care-style management cut dementia cases by double digits over several years, though not every blood-pressure trial has shown the same result for dementia itself. The sections below break down what works, what the evidence does not yet support, and what a reader can reasonably ask a primary care clinician to do.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does the strongest trial evidence show?
- Why would primary care affect dementia risk at all?
- What can't primary care do yet — screening limits
- What should a reader actually ask for at a primary care visit?
- Does continuity of care matter after a diagnosis?
- Frequently Asked Questions
What does the strongest trial evidence show?
The China Rural Hypertension Control Program (CRHCP) enrolled 33,995 adults aged 40 and older with hypertension and had non-physician health workers manage their blood pressure the way a primary care practice would — titrating medication toward a target below 130/80 mmHg. Over about seven years, this reduced all-cause dementia incidence by 15% compared with usual care, according to CRHCP trial results reported by HCPLive. The same trial found a 16% reduction in cognitive impairment without dementia, meaning the benefit showed up earlier, at the stage of milder decline, not only at the point of full dementia diagnosis, according to the CRHCP findings. That matters for primary care specifically because the intervention did not require a specialist or a memory clinic — it was routine blood pressure management delivered at scale, sustained over years.
This result is not universal, however. The NIH-funded SPRINT MIND trial, run in US adults with hypertension, tested an even more intensive systolic blood pressure target of under 120 mmHg. It significantly reduced new mild cognitive impairment but did not produce a statistically significant reduction in probable dementia itself over roughly five years, according to NIH's report on the trial. The shorter follow-up window in SPRINT MIND, compared with CRHCP's seven years, is one plausible reason the dementia effect didn't reach significance even though the earlier-stage cognitive benefit did.
Why would primary care affect dementia risk at all?
Primary care is where most of the conditions on the Lancet Commission's list of 14 modifiable risk factors actually get diagnosed and treated. Hypertension, type 2 diabetes, obesity, smoking, depression, hearing loss, and high LDL cholesterol are all things a primary care clinician screens for, treats, or refers out for, often over years of repeat visits, per the Lancet Commission.
None of these factors causes dementia on its own, and controlling any single one does not guarantee prevention for any individual patient. What the Lancet Commission's estimate describes is population-level potential: if these 14 factors were addressed effectively across a population, a substantial share of dementia cases could be prevented or delayed. The CRHCP blood pressure trial is the clearest real-world demonstration of that population effect translating into measured outcomes.
What can't primary care do yet — screening limits
Primary care's role in managing risk factors is well supported, but its role in actively screening for early cognitive decline is more limited by current guidance. The U.S. Preventive Services Task Force concluded that the evidence is insufficient to recommend for or against routine cognitive-impairment screening in asymptomatic, community-dwelling adults 65 and older, according to the USPSTF recommendation.
This is an "insufficient evidence" finding, not a recommendation against screening — it means researchers don't yet know whether routine screening in people with no symptoms changes outcomes enough to justify it broadly. Medicare already requires something narrower: primary care clinicians must assess cognitive function by direct observation at every Annual Wellness Visit. However, the Centers for Medicare & Medicaid Services has not mandated a specific validated screening tool for this assessment, according to CMS's cognitive assessment policy. That means how thoroughly this gets done — and how it gets documented — varies from one practice to another.
- Ask whether your Annual Wellness Visit included a direct cognitive assessment, not just a questionnaire you filled out yourself.
- Ask which tool was used, since practices are not required to standardize on one.
- Don't expect a cognitive screening test by default at a routine visit outside the Annual Wellness Visit — it is not a universal requirement.
What should a reader actually ask for at a primary care visit?
Given the evidence, the most concrete, evidence-backed request a reader can make is sustained blood pressure control, not a one-time check. The CRHCP result came from years of consistent management toward a specific target, not a single prescription change, according to the CRHCP trial.
- Confirm your blood pressure target with your clinician and ask how it compares to 130/80 mmHg.
- Ask about the other factors on the Lancet Commission's list that apply to you — diabetes, cholesterol, smoking, hearing loss, depression — since each is independently modifiable in a primary care setting.
- Request your Annual Wellness Visit cognitive assessment explicitly if you're on Medicare and unsure whether one has been done.
- Keep follow-up visits consistent rather than sporadic, since the trial evidence for dementia benefit comes from years of sustained management, not a single intervention.
Does continuity of care matter after a diagnosis?
The evidence above concerns prevention — lowering the risk of developing dementia. A separate UK study looked at what happens after diagnosis, when continuity of care becomes a quality-of-care question rather than a prevention one.
Among 32,799 people who died with a dementia diagnosis between 2009 and 2018, those who had perfect continuity of care with a single GP incurred about £2,097 lower health and social care costs in their final year of life, according to the British Journal of General Practice study. This points to a practical benefit of staying with one regular primary care clinician after a dementia diagnosis — it does not suggest that continuity of care itself lowers the risk of developing dementia in the first place.
Frequently Asked Questions
Does lowering blood pressure always reduce dementia risk?
Not in every trial. CRHCP showed a 15% reduction in dementia over about seven years, per HCPLive's report, while the shorter SPRINT MIND trial found a benefit for mild cognitive impairment but not a statistically significant one for probable dementia, per NIH.
Will my doctor automatically screen me for dementia at a checkup?
Only at the Medicare Annual Wellness Visit, where direct cognitive observation is required, though no specific test is mandated, per CMS. Routine screening in symptom-free adults is not otherwise recommended either way, per the USPSTF.
What share of dementia cases could primary-care-managed risk factors prevent?
Up to 45% globally, according to the 2024 Lancet Commission, which identified 14 modifiable risk factors largely managed in primary care settings.
